Feed 4172.TWO
41
InnoPharmax Inc.
4172.TWO · TWO
$11.00 -2.65% (-$0.30)
1M -13.58%
Market Cap $1.3B
P/E Ratio -
Div. Yield -
ROE 36.72%
Valuation
32 /100
Expensive P/B 3.17x
P/S 19.29x
EV/FFO N/A
Growth
82 /100
Growing Book val. growth 0.92%
Rev. growth 33.29%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 248.98%
Gross margin 5.08%
FCF margin 195.29%
Quality
2 /100
Poor ROA 39.32%
ROIC 40.70%
Asset turnover 0.15x
Debt
69 /100
Low Int. coverage -448.46x
Debt/Equity 0.03x
Current ratio 3.52x
Stability
11 /100
Unstable EPS volatility 52.55%
Beta 0.02x
Profitable years 0
Vprašajte StockBota o 4172.TWO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Weihua Hao
Employees
34
Headquarters
Taipei